Bharat Biotech setting up 4 vaccine manufacturing facilities

By: |
Updated: Jan 04, 2021 8:46 PM

Denying allegations that the city-based vaccine maker lacks data of Covaxin, Krishna Ella, chairman of Bharat Biotech, said sufficient data has already been revealed and is available on the net.

Coronavirus vaccine, Coronavirus vaccine India, Coronavirus vaccine update, Coronavirus vaccine update Delhi, Coronavirus vaccine update India, Coronavirus vaccine news, Coronavirus vaccine India, Coronavirus vaccine tracker, Coronavirus vaccine latest news, Coronavirus vaccine progress, Coronavirus vaccine latest update, covid 19 India, covid 19 vaccine, covid 19 vaccine updateCovaxin is currently undergoing phase 3 clinical trials with 24,000 volunteers.

Bharat Biotech, which has been accorded Emergency Use Authorisation from the drug regulator for its COVID-19 vaccine Covaxin, on Monday said they are setting up four vaccine manufacturing facilities with a combined capacity of 700 million doses per annum. Denying allegations that the city-based vaccine maker lacks data of Covaxin, Krishna Ella, chairman of Bharat Biotech, said sufficient data has already been revealed and is available on the net.

“We have four facilities coming up. We are planning around 200 million doses (per annum) in Hyderabad, 500 million doses in other cities. By 2021 we will have 700 million doses capacity… as we speak we have 20 million doses, he told reporters. He said Covaxin is currently undergoing phase 3 clinical trials with 24,000 volunteers.

“I think we are the only company I can categorically say has got extensive research experience and extensive publication peer reviewed journals. Many people say that I am not transparent in my data. I think people should have the patience to read internet and look at what our articles are,” he said on the allegations of data availability. He said Indian companies are being targeted as inferior ones and said his companys work is no less than Pfizer, which also came out with a vaccine for coronavirus.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Pakistan approves emergency use of Russia’s Sputnik V COVID-19 vaccine
2Year after lockdown, Wuhan dissident more isolated than ever
3Aviation sector workers be vaccinated on priority after health workers: MoCA to MoHFW